Page last updated: 2024-09-04

pixantrone and Sarcoma 180

pixantrone has been researched along with Sarcoma 180 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deng, Y; Hu, L; Jia, X; Li, C; Liu, M; Liu, X; Liu, Y; Lu, M; Luo, X; McClements, DJ; Qiu, Q; Song, Y; Zhang, T; Zhou, S	1

Other Studies

1 other study(ies) available for pixantrone and Sarcoma 180

Article	Year
Targeted delivery of pixantrone to neutrophils by poly(sialic acid)-p-octadecylamine conjugate modified liposomes with improved antitumor activity. International journal of pharmaceutics, 2018, Aug-25, Volume: 547, Issue:1-2 Topics: Amines; Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Isoquinolines; Liposomes; Male; Mice; N-Acetylneuraminic Acid; Neutrophils; Particle Size; Rats; Rats, Wistar; Sarcoma 180; Tumor Microenvironment; Xenograft Model Antitumor Assays	2018

Article

Year

Targeted delivery of pixantrone to neutrophils by poly(sialic acid)-p-octadecylamine conjugate modified liposomes with improved antitumor activity.

International journal of pharmaceutics, 2018, Aug-25, Volume: 547, Issue:1-2

Topics: Amines; Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Isoquinolines; Liposomes; Male; Mice; N-Acetylneuraminic Acid; Neutrophils; Particle Size; Rats; Rats, Wistar; Sarcoma 180; Tumor Microenvironment; Xenograft Model Antitumor Assays

2018